calmodulin inhibitor w7

Calmodulin modulates prolactin secretion in vitro: studies with.
Subcellular mechanism for Ca(2+)-dependent enhancement of.
Identification of calmodulin-like activity in term human amnion: effect.
In this study we have demonstrated that the specific calmodulin inhibitors. inhibit NK activity in humans at IC50's of 6.9 microM for W7 and 5.2 microM for W13.
As reported for cyclic nucleotide-gated channels in sensory neurons, we investigated the action of Ca2+–calmodulin and calmodulin antagonist (W7) on the.
Nov 5, 1988. Inhibition of inositol trisphosphate-stimulated calcium mobilization by. of naphthalenesulfonamide calmodulin antagonists, W7 and W13, and.

Mouse hypothalamic somatostatin release: roles of calcium and.

The similarity of the inhibitory curves for CAPP1-calmodulin, W7, and calmidazolium suggests that all these agents inhibit mitosis by antagonizing intracellular.
To test the calmodulin involvement in these processes we used either selective calmodulin antagonist, the naphthalene sulphonamide derivative W7.

Calcium-independent growth of human ovarian carcinoma cells.

The Platelets: Physiology And Pharmacology - Google Books Result.

Naphthalenesulfonamide derivatives ML9 and W7 inhibit catecholamine. and the calmodulin antagonist W7 inhibited catecholamine secretion 20 and 40br> A Novel Ca2+/Calmodulin Antagonist HBC Inhibits Angiogenesis.